We are live on ! Find out more
GYRE icon

Gyre Therapeutics
GYRE

64 hedge funds and large institutions have $117M invested in Gyre Therapeutics in 2014 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

637% more call options, than puts

Call options by funds: $2.31M | Put options by funds: $313K

17% more capital invested

Capital invested by funds: $100M → $117M (+$16.9M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

14% less funds holding

Funds holding: 74 → 64 (-10)

14% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 21

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

Holders
64
Holders Change
-10
Holders Change %
-13.51%
% of All Funds
1.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
18
Reduced
21
Closed
17
Calls
$2.31M
Puts
$313K
Net Calls
+$1.99M
Net Calls Change
+$978K

Top Buyers

1
CCM
Camber Capital Management
Massachusetts
+$6.46M
2
Franklin Resources
Franklin Resources
California
+$5.21M
3
SCM
Sarissa Capital Management
Connecticut
+$1.55M
4
TC
TFS Capital
Pennsylvania
+$670K
5
AIA
Arbor Investment Advisors
North Carolina
+$489K

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$3.88M
2
SFM
Sphera Funds Management
Israel
-$1.25M
3
BC
Broadfin Capital
New York
-$1.24M
4
Goldman Sachs
Goldman Sachs
New York
-$1.05M
5
Millennium Management
Millennium Management
New York
-$992K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIM
26
BlackRock Investment Management
Delaware
$461K +$3.7K +1 +0.8%
Los Angeles Capital Management
27
Los Angeles Capital Management
California
$456K +$452K +122 New
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$369K – – –
Connor, Clark & Lunn Investment Management (CC&L)
29
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$362K +$326K +88 New
Barclays
30
Barclays
United Kingdom
$328K +$318K +86 +478%
Two Sigma Investments
31
Two Sigma Investments
New York
$302K -$248K -67 -45%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$239K – – –
PPA
33
Parametric Portfolio Associates
Washington
$227K – – –
TA
34
Teachers Advisors
New York
$225K – – –
Invesco
35
Invesco
Georgia
$199K -$22.2K -6 -10%
PAM
36
Panagora Asset Management
Massachusetts
$186K -$7.4K -2 -4%
OA
37
Oak Associates
Ohio
$183K – – –
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$178K -$3.7K -1 -2%
Charles Schwab
39
Charles Schwab
California
$177K – – –
State Board of Administration of Florida Retirement System
40
State Board of Administration of Florida Retirement System
Florida
$168K – – –
VRS
41
Virginia Retirement Systems
Virginia
$159K – – –
ARTA
42
A.R.T. Advisors
New York
$158K +$74K +20 +91%
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$152K – – –
NFA
44
Nationwide Fund Advisors
Ohio
$144K -$3.7K -1 -3%
ProShare Advisors
45
ProShare Advisors
Maryland
$134K +$133K +36 New
Group One Trading
46
Group One Trading
Illinois
$123K -$152K -41 -55%
CS
47
Credit Suisse
Switzerland
$116K -$118K -32 -51%
AllianceBernstein
48
AllianceBernstein
Tennessee
$114K -$18.5K -5 -14%
Millennium Management
49
Millennium Management
New York
$110K -$992K -268 -90%
BA
50
BlackRock Advisors
Delaware
$110K -$74K -20 -41%
1
2
3 4

GYRE Hedge Fund Activity: Q1 2014 in Review

64 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Gyre Therapeutics (GYRE) for Q1 2014, worth a combined $117M — up 17% from $100M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of GYRE and 8 opened new positions — a net loss of 9 holders — while 21 trimmed existing stakes and 18 added.

The largest buyer was Camber Capital Management, adding an estimated $6.46M. The largest seller was Wellington Management Group, exiting entirely with an estimated $3.88M sold.

  • 64 institutional investors held Gyre Therapeutics (GYRE) as of Q1 2014, down from 74 in Q4 2013.
  • Funds reported $117M of Gyre Therapeutics stock for Q1 2014, up 17% quarter-over-quarter.
  • 8 funds opened new Gyre Therapeutics positions in Q1 2014 and 17 closed out, a net change of -9 holders.
  • The largest Gyre Therapeutics buyer in Q1 2014 was Camber Capital Management, an estimated $6.46M added.
  • The largest Gyre Therapeutics seller in Q1 2014 was Wellington Management Group, an estimated $3.88M sold.

Based on aggregated 13F filings for Q1 2014.